Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet.
An isocaloric low-protein (LP) diet (8% instead of 20% in controls) given to dams during gestation reduces the fractional insulin release of stimulated fetal islets. The LP diet lowers the plasma concentration of taurine in both pregnant rats and their fetuses. This study reports the effect of taurine on the in vitro release of insulin from control and LP fetal islets. Direct stimulation with taurine, methionine or leucine increased the release of insulin from control islets. Nevertheless, no effect on LP islets was observed with either taurine or methionine. The release of insulin from LP islets was reduced with leucine. The in vitro addition of taurine (0. 3 or 3 mM) to the culture medium increased the release of insulin from the control islets in response to arginine or leucine, but it did not restore the reduced responsiveness of LP islets to these amino acids. When 2.5% taurine was added to the drinking water of control or LP dams (groups C+T and LP+T) throughout gestation, the concentration of taurine increased in the serum of dams and fetuses of both groups. The release of insulin from the LP+T fetuses was restored to control levels when stimulated with taurine, methionine, leucine or arginine. In conclusion, taurine stimulated control fetal islets in vitro, but failed to do so in LP islets. However, the addition of taurine to the diet of LP dams restored to normal the release of insulin from LP fetal islets, indicating the importance of taurine during development for a normal fetal beta cell function.
Cherif
H
H
Laboratoire de Biologie Cellulaire, World Health Organization Collaborating Center for the Development of the Biology of the Endocrine Pancreas, Université Catholique de Louvain, B-1348 Louvain-la-Neuve, Belgium.
Reusens
B
B
Ahn
M T
MT
Hoet
J J
JJ
Remacle
C
C
D000704:Analysis of Variance; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D046508:Culture Techniques; D018753:Diet, Protein-Restricted; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000196:embryology* / Q000378:metabolism*; D007930:Leucine / Q000494:pharmacology; D008431:Maternal-Fetal Exchange; D008715:Methionine / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D013268:Stimulation, Chemical; D013654:Taurine / Q000097:blood / Q000494:pharmacology*
D007328:Insulin; D013654:Taurine; D001120:Arginine; D008715:Methionine; D007930:Leucine